@article{47e29437ba5842acbb6f8192e6b11f85,
title = "The Power of Systems Biology: Insights on Lupus Nephritis from the Accelerating Medicines Partnership",
keywords = "Accelerating medicines partnership, AMP, Biomarker, Lupus nephritis, Proteomics, scRNA-seq, SLE, Transcriptomics",
author = "Andrea Fava and Soumya Raychaudhuri and Rao, {Deepak A.}",
note = "Funding Information: A. Fava is supported by the Accelerated Medicines Partnership (AMP) NIH UH2 AR067679 , the Hopkins Lupus Cohort NIH R01 AR069572 , the Cupid Foundation, and the Jerome L Greene Foundation . D.A. Rao is supported by the AMP NIH UH2 AR06768 , Lupus Research Alliance , Burroughs Wellcome Fund Career Award for Medical Sciences, and NIH NIAMS K08 AR072791 . Funding Information: A. Fava is supported by the Accelerated Medicines Partnership (AMP) NIH UH2 AR067679, the Hopkins Lupus Cohort NIH R01 AR069572, the Cupid Foundation, and the Jerome L Greene Foundation. D.A. Rao is supported by the AMP NIH UH2 AR06768, Lupus Research Alliance, Burroughs Wellcome Fund Career Award for Medical Sciences, and NIH NIAMS K08 AR072791. Dr D.A. Rao reports personal fees from Pfizer, Janssen, Merck, Bristol-Myers Squibb, and Scipher Medicine; and grants from Janssen and Bristol-Myers Squibb outside the submitted work. Dr S. Raychaudhuri reports personal fees from Gilead, Mestag, Biogen, and Merck; and grants from Biogen and Bristol-Myers Squibb.",
year = "2021",
month = aug,
doi = "10.1016/j.rdc.2021.04.003",
language = "English (US)",
volume = "47",
pages = "335--350",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders",
number = "3",
}